🇺🇸 FDA
Patent

US 9303064

Peptide inhibiting matrix metalloproteanases activity and use thereof

granted A61KA61K2800/782A61K31/728

Quick answer

US patent 9303064 (Peptide inhibiting matrix metalloproteanases activity and use thereof) held by CAREGEN CO., LTD. expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2800/782, A61K31/728, A61K38/00, A61K38/08